Connect with us

Hi, what are you looking for?

Sunday, Apr 20, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "Metabolic dysfunction-associated steatohepatitis"

Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment

Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment

Medical and Pharmaceutical

Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment

Relacorilant is designed to address disorders linked to the stress hormone cortisol

Joseph MortonMarch 31, 2025

Sagimet Biosciences up 30% on strong clinical stage data

Sagimet Biosciences up 30% on strong clinical stage data

Medical and Pharmaceutical

Sagimet Biosciences up 30% on strong clinical stage data

Denifanstat received FDA Breakthrough Therapy designation for metabolic dysfunction-associated steatohepatitis

Joseph MortonDecember 16, 2024

More Posts